SCHEMBL2445992

SCHEMBL2445992

CCN(CC)CCNC(=O)c1cccc2c(Cl)c3ccccc3nc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 5/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
POLR1A O95602 3/20 0.58
HPGD P15428 3/20 0.55
GAA P10253 2/20 0.55
CYP1A2 P05177 2/20 0.55
KCNH2 Q12809 2/20 0.55
LMNA P02545 2/20 0.55
ABCB11 O95342 1/20 0.55
CYP2D6 P10635 1/20 0.55
SCN1A P35498 1/20 0.55
OPRK1 P41145 1/20 0.55
CACNA1C Q13936 1/20 0.55
SCN5A Q14524 1/20 0.55
GHSR Q92847 1/20 0.55
SCN2A Q99250 1/20 0.55
SCN3A Q9NY46 1/20 0.55
ALOX15 P16050 1/20 0.54
HTT P42858 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17512891 0.90 RAD52 (0.52) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL14116120 0.89 RAD52 (0.67) ALDH1A1KDM4ESMN1; SMN2POLR1ACYP1A2
SCHEMBL2445675 0.88 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL2445747 0.86 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL2442596 0.86 KDM4E (0.51) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL17874525 0.85 ACACB (0.48) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL2447168 0.81 KDM4E (0.69) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL23722839 0.81 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL30147384 0.81 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD
SCHEMBL30147383 0.81 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2POLR1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046789-B1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INST NAT SANTE RECH MED (FR) 2012-09-05 EP disclosed
EP-2363399-A1 Labelled analogues of halobenzamides as radiopharmaceuticals INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2011-09-07 EP disclosed
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed
EP-2046789-A2 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2009-04-15 EP disclosed
WO-2008012782-A2 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS HRH3, H1-3, HRH4 ALDH1A1 794/4885KDM4E 3466/4885SMN1; SMN2 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.